Guillem will be responsible for sourcing and evaluating investment opportunities. As a Principal he will also represent Ysios as member of the board of its portfolio companies.
Guillem is a CFA charterholder and holds a bachelor’s degree in Biotechnology from the Universitat Autonoma de Barcelona and a bachelor’s degree in Business Administration from the Universitat Pompeu Fabra. Previously, Guillem was Associate at Edmond de Rothschild group (now Andera Partners). Before joining Edmond de Rothschild group in 2013, Guillem started his career at Caixa Capital Risc, in the life sciences team.

“We have known Guillem for a long time and are very pleased he now has joined our team. His experience will be very valuable in helping us continue to invest in promising life sciences companies developing truly differentiated drugs for unmet medical needs”, commented Joël Jean-Mairet, Managing Partner at Ysios.